Literature DB >> 1961645

Leiomyosarcoma of the conjunctiva.

V A White1, K F Damji, J S Richards, J Rootman.   

Abstract

The clinical, light microscopic, immunohistologic, and ultrastructural findings of a leiomyosarcoma of the conjunctiva are presented. This tumor was diagnosed after a 26-year history and is the first to be adequately documented as having arisen in the conjunctiva.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1961645     DOI： 10.1016/s0161-6420(91)32087-6

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


  7 in total

1.  Primary monophasic synovial sarcoma of the conjunctiva.

Authors:  M Votruba; J Hungerford; P G S Cornes; D Mabey; P Luthert
Journal:  Br J Ophthalmol       Date:  2002-12       Impact factor: 4.638

2.  Orbital leiomyosarcoma metastasis presenting prior to diagnosis of the primary tumor.

Authors:  Nailyn Rasool; Daniel R Lefebvre; Mark A Latina; Ian F Dunn; Sandro Santagata; Suzanne K Freitag; Dean M Cestari
Journal:  Digit J Ophthalmol       Date:  2017-12-31

3.  [Subcutaneous leiomyosarcoma metastatic to the eyelid].

Authors:  J Wrede; H E Völcker; S Dithmar
Journal:  Ophthalmologe       Date:  2007-01       Impact factor: 1.059

4.  Conjunctival leiomyosarcoma.

Authors:  Aluisio Rosa Gameiro Filho; Ana Marisa Pires Castello Branco; Moacyr Pezati Rigueiro; Melina Correia Morales; Rubens N Belfort
Journal:  Am J Ophthalmol Case Rep       Date:  2022-05-11

5.  Conjunctival Leiomyosarcoma, a Rare Neoplasm Always Originating at the Limbus? Report of a New Case and Review of 11 Published Cases.

Authors:  V De Groot; E Verhelst; P C W Hogendoorn; R J W de Keizer
Journal:  Ocul Oncol Pathol       Date:  2019-01-24

6.  Conjunctival leiomyosarcoma: A fairly common tumour in an uncommon site.

Authors:  Reubina Wadee
Journal:  SAGE Open Med Case Rep       Date:  2017-08-09

Review 7.  Conjunctival leiomyosarcoma: A case report and review of literature.

Authors:  Tania Lopez Montes; Maria Varela Agra; Mario San Martin Alonso; Alberto Ollero Lorenzo
Journal:  Indian J Ophthalmol       Date:  2017-05       Impact factor: 1.848
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.